三硬脂基原甲酸酯 | 17671-28-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 三硬脂基原甲酸酯
• 英文名称: tris-octadecyloxy-methane
• 英文别名: orthoformic acid trioctadecyl ester；tris(octadecyl)-orthoformic acid；1,1',1''-(Methylidynetris(oxy))trisoctadecane；1-(dioctadecoxymethoxy)octadecane
• CAS: 17671-28-2
• 化学式: C₅₅H₁₁₂O₃
• 分子量: 821.492
• InChiKey: AZJIEXRJDXOMAN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  26.5
• 重原子数：
  58
• 可旋转键数：
  54
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  27.7
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  膦胺霉素 、 三硬脂基原甲酸酯 在 甲醇 、 Octadecyl formate 作用下， 反应 2.0h， 以to obtain 12 as a highly viscous oil的产率得到3-(N-Formyl-N-Hydroxylamino)-Propylphosphonic Acid Dioctadecyl-Ester
  参考文献：
  名称：

  Use of organophosphorus compounds for the therapeutic and prophylactic treatment of infections

  摘要：

  使用一般式（I）1的有机磷化合物，治疗和预防由病毒、真菌和寄生虫引起的人和动物感染。

  公开号：

  US20040082549A1

文献信息

• [EN] FUNCTIONALIZED α-ANGELICA LACTONE MONOMERS AND POLYMERS OBTAINED THEREFROM<br/>[FR] MONOMÈRES α-ANGELICA LACTONE ET POLYMÈRES OBTENUS À PARTIR DE CEUX-CI
  申请人：HENKEL AG & CO KGAA

  公开号：WO2020212041A1

  公开（公告）日：2020-10-22

  The present invention is directed to a monomer for chain growth polymerization, in particular anionic polymerization, said monomer having the general formula (EFL) wherein: Ra is a C3-C30 alkyl, C3-C30 cycloalkyl, C6-C18 aryl or C2-C12 alkenyl group. The present invention is further directed to a process for the anionic polymerization of at least one compound (EFL) as defined above, wherein said anionic polymerization is conducted in the presence of an initiator selected from the group consisting of: alkali metal organyls; alkali metal alkoxides; alkali metal thiolate; alkali metal amides; and, compounds of an element of group 3a of the Periodic Table of the Elements. The process of anionic polymerization yields a homo- or co-polymer (p-EFL) having pendant lactone functional groups in its repeating units.

  本发明涉及一种用于链增长聚合的单体，特别是阴离子聚合，所述单体具有通式（EFL），其中：Ra是C3-C30烷基，C3-C30环烷基，C6-C18芳基或C2-C12烯基基团。本发明进一步涉及一种用于上述定义的至少一种化合物（EFL）的阴离子聚合的方法，其中所述阴离子聚合在以下引发剂的存在下进行：碱金属有机基；碱金属烷氧基；碱金属硫醇酸盐；碱金属酰胺；以及元素3a族化合物。阴离子聚合的方法产生具有其重复单元中端基内酯官能团的同聚物或共聚物（p-EFL）。
• USE OF ORGANOPHOSPHORUS COMPOUNDS FOR THE THERAPEUTIC AND PROPHYLACTIC TREATMENT OF INFECTIONS
  申请人：Jomaa Hassan

  公开号：US20110306578A1

  公开（公告）日：2011-12-15

  Use of organophosphorus compounds of general Formula (I) for the therapeutic and prophylactic treatment of infections in humans and animals caused by viruses, fungi and parasites.

  使用一般式（I）的有机磷化合物治疗和预防人和动物感染病毒、真菌和寄生虫引起的感染。
• FUNCTIONALIZED ALPHA-ANGELICA LACTONE MONOMERS AND POLYMERS OBTAINED THEREFROM
  申请人：Henkel AG & Co. KGaA

  公开号：EP3725784A1

  公开（公告）日：2020-10-21

  The present invention is directed to a monomer for chain growth polymerization, in particular anionic polymerization, said monomer having the general formula (EFL) wherein: Ra is a C1-C30 alkyl, C3-C30 cycloalkyl, C6-C18 aryl or C2-C12 alkenyl group. The present invention is further directed to a process for the anionic polymerization of at least one compound (EFL) as defined above, wherein said anionic polymerization is conducted in the presence of an initiator selected from the group consisting of: alkali metal organyls; alkali metal alkoxides; alkali metal thiolate; alkali metal amides; and, compounds of an element of group 3a of the Periodic Table of the Elements. The process of anionic polymerization yields a homo- or co-polymer (p-EFL) having pendant lactone functional groups in its repeating units.

  本发明涉及一种用于链增长聚合，特别是阴离子聚合的单体，所述单体具有通式 (EFL) 其中Ra 是 C1-C30 烷基、C3-C30 环烷基、C6-C18 芳基或 C2-C12 烯基。本发明进一步涉及至少一种如上定义的化合物（EFL）的阴离子聚合工艺，其中所述阴离子聚合是在选自以下组别的引发剂存在下进行的：碱金属羰基；碱金属烷氧基；碱金属硫酸盐；碱金属酰胺；以及元素周期表 3a 族元素的化合物。阴离子聚合过程产生的均聚物或共聚物（p-EFL）在其重复单元中具有悬挂的内酯官能团。
• USE OF FUNCTIONALIZED ALPHA-ANGELICA LACTONES
  申请人：Henkel AG & Co. KGaA

  公开号：EP3725820A1

  公开（公告）日：2020-10-21

  The present invention is directed to the use as a reactive component in the curing of compositions based on epoxy resins of a functionalized α-angelica lactone (XOMAL) having the general formula: wherein: Ra is a C1-C30alkyl, C3 -C30 cycloalkyl, C6-C18 aryl or C2-C12 alkenyl group.

  本发明的目的是将具有通式的官能化 α-当归内酯 (XOMAL) 用作基于环氧树脂的组合物固化过程中的活性组分： 其中Ra 是 C1-C30 烷基、C3-C30 环烷基、C6-C18 芳基或 C2-C12 烯基。
• A facile etherification procedure for 3β-hydroxy-Δ5-steroids
  作者：John P. Dasza、Joseph P. Joseph、Seymour Bernstein

  DOI：10.1016/0039-128x(66)90045-6

  日期：1966.10